Literature DB >> 28841634

Mammalian target of rapamycin complex 1 and FoxO1 in the transcriptional control of lipolysis and de novo lipogenesis.

Konstantin V Kandror1.   

Abstract

PURPOSE OF REVIEW: Postprandial suppression of lipolysis in adipose tissue and stimulation of de novo lipogenesis (DNL) in the liver by insulin are essential for the metabolic homeostasis in the mammalian organism. The mechanism of coregulation of lipolysis and DNL is not clear. RECENT
FINDINGS: Insulin controls both lipolysis and DNL at the level of transcription via the same mammalian target of rapamycin complex 1 (mTORC1) and FoxO1-mediated signaling pathways.
SUMMARY: mTORC1 suppresses lipolysis in adipose tissue and activates DNL in the liver, whereas FoxO1 has the opposite effect. Individual inputs of either mTORC1 or FoxO1 in the regulation of lipid metabolism may be difficult to evaluate because of the cross talk between these pathways.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28841634     DOI: 10.1097/MED.0000000000000352

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  1 in total

1.  FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes.

Authors:  Yujing Chi; Yuhong Meng; Junpei Wang; Weili Yang; Zhe Wu; Mei Li; Di Wang; Fangfang Gao; Bin Geng; Lu Tie; Weiping Zhang; Jichun Yang
Journal:  J Cell Mol Med       Date:  2018-11-28       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.